100 likes | 231 Views
In this report, the antibody production market is segmented on the basis of process and end users. On the basis of process, the market is categorized into upstream processing, downstream processing, and filtration.
E N D
MarketsandMarkets Presents Antibody Production Market worth 13.28 Billion USD by 2021 http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
The report "Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021", that analyzes and studies the major market drivers, restraints, challenges, and opportunities. Browse 221 market data Tables and 38 Figures spread through 211 Pages and in-depth TOC on "Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021" http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
Early buyers will receive 10% customization on this report. http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
This report studies the antibody production market for the forecast period of 2016 to 2021. This market is expected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3%. A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are key drivers for the growth of the antibody production market. Moreover, the increasing risk of infectious diseases and rising demand for protein therapeutics are expected to drive market growth during the forecast period. http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
In this report, the antibody production market is segmented on the basis of process, end user, and region. Based on process, the antibody production market is categorized into products for upstream processing, downstream processing, and filtration. The downstream processing segment is expected to account for the largest share of the antibody production market in 2016. This segment is also projected to register the highest CAGR during the forecast period. http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
On the basis of end user, the antibody production market is segmented into pharmaceutical and biotechnology companies, research institutes, and diagnostic laboratories. The pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market in 2016, and is projected to register the highest CAGR during the forecast period. http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
Geographically, the global antibody production market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the antibody production market in 2016, followed by Europe. The Asia-Pacific region offers significant growth opportunities for companies offering antibody production products, and is projected to grow at the highest CAGR during the forecast period. http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
Prominent players in the antibody production market include GE Healthcare (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), Sigma-Aldrich Corporation (Germany), Eppendorf AG (Germany), Cellab GmbH (Germany), INTEGRA Biosciences AG (Switzerland), and FiberCell Systems Inc. (U.S.). http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
Contact Us Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html
About MarketsandMarkets MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html